Guest Editors
Dr. Ali BOURGI
Email: a.bourgi@chu-tours.fr
Affiliation: Department of Urology, University Hospital of Tours, 37044 Tours, France
Homepage:
Research Interests: Bladder cancer, urothelial carcinoma, health data analysis, treatment pathways, immunotherapy, biomarkers
Summary
Bladder cancer remains one of the most challenging urological malignancies due to its high recurrence rate, therapeutic complexity, and molecular heterogeneity. With the advent of novel molecular diagnostics, immunotherapies, and risk stratification tools, the clinical landscape of bladder cancer management is rapidly evolving. This Special Issue aims to bring together cutting-edge research and expert reviews addressing the full spectrum of bladder cancer care—from early detection and epidemiology to biomarkers, surgical advances, systemic therapies, and survivorship.
The Special Issue will serve as a comprehensive platform for discussing translational and clinical breakthroughs, highlighting multidisciplinary approaches and innovations. Particular attention will be paid to personalized medicine, integration of omics technologies, the role of microbiome and immunotherapy, and real-world data on treatment pathways.
Suggested Themes
· Epidemiology and prevention of bladder cancer
· Molecular classification and biomarkers
· Role of DNA damage response in therapy
· Surgical innovations and robotic approaches
· BCG treatment strategies and alternatives
· Immunotherapy and checkpoint inhibitors
· Microbiome and tumor immunity
· Real-world evidence and SNDS/claims-based analyses
· Survivorship and quality of life
We invite researchers and clinicians from diverse disciplines—including urologic oncology, medical and radiation oncology, molecular biology, and health policy—to contribute to this Special Issue. By combining expertise across these fields, we aim to accelerate the translation of research findings into clinical practice and ultimately enhance outcomes and quality of care for patients with bladder and prostate cancers.
Keywords
Bladder cancer, urothelial carcinoma, immunotherapy, biomarkers, molecular classification, SNDS, epidemiology, microbiome, surgery
Published Papers
Login
Register
Submit a Paper
Propose a Special lssue